Incretin Microdosing for Cardiometabolic Health in People With HIV

NCT07325500 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Weight Gain

Interventions

DRUG: Dose escalation to 2 mg semaglutide weekly then semaglutide microdosing at 0.5 mg weekly
DRUG: Dose escalation to 2 mg semaglutide weekly then no semaglutide

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]
[object Object]
[object Object]